The management is playing games, like Stanley Crooke at ISIS. Valued at 2Xcash and only about $14 million???
It is so suspicious to see a man going to preside over the board of the bed bug company after making multibillion deals. Got nothing better to do but roll in the dirt and ruin his reputation. Why would Berlin even mention his past credentials when the only thing he has done is a near death performance . all time lows and going. What was that show with options blah blah blah...
Just FYI but under their corporate presentation Brian Markison (Chairman of Board for ROSG)
Experienced CEO of major pain and dermatology companies CEO of Fougera Pharmaceuticals sold to Novartis (July 2012); CEO of King Pharmaceuticals sold to Pfizer (Feb.2011)
Fougera for 1.5 Billion
King Pharma for 3.6 Billion
Now this was when Brian was CEO so hopefully he can kick Berlin in the balls and have him sell ROSG! It will sell just might be in 3 years.
A sensible attitude, and certainly possible. I would be very happy if the market reacts to good news by the end of March. But my suspicious nature expects a few more quarters of hard data to indicate a successful revenue stream before Wall Street pays much attention.
I don't expect anything next month. I did add a couple thousand today.Any news will likely be on March 31 for the second half of 2014. Then if money starts coming in from partnerships, and sales and billings are still increasing - we will see, Otherwise, the buy-out potential is always there.
You took the words right out of my mouth, or fingers, as the case may be. The company has had a lot of ill will to overcome, and that takes time and "proof of life." In the past six months, we have seen those vital signs getting stronger. The patient is not out of the woods yet, but the prognosis is getting better, so I'm hoping to see a full recovery in 2015. The Moffitt connection is a high positive, and I am watching for partnerships and approvals you mentioned. GLTA who have continued to do their due diligence and held shares because the company's future continues on a positive path.
I want to comment on your comment "someone pulled a rug from underneath a bunch of them". I suspect that is exactly what happened. Sometime back I was winning on three trades on tiny sub $5.00 stocks. In the exact second all three hit huge volume and instantly I was in the red. This isn't supposed to happen to stocks this cheap. The market is rigged. I have no doubt.
If and when medicare pays for the kidney and lung tests that's more and more products with a need that are being paid for by insurance. Profits can only grow (or so I hope).
I'm looking to add soon. Best wishes.
Dip... what are you expecting next month? Is it the earnings? I'm not sure. However, we agree and I'm looking to add to my position because this company is executing on it's marketing plan and I can see that. They have tons of partners now, products that have a need and insurance companies to pay for the products to supply the need. I really don't understand why this stock isn't soaring. If just one of those partnerships gets a product created that will change the world. What is it that you're expecting next month? Please advise.
Google says at the end of the month. This would be typical for the last day (90 days) from the end on last quarter (july-Sept) Any other word? If the management can't find out what they sold sooner than that, no wonder! In reality we won't know until the end of March what July saales were.
These guys are awesome, and they have a new report due out this evening. Don't miss out on a golden opportunity to see why they are the best in the business
12K bid @ $2.29 sat there all morning long and no one bothered to fill it on the down day ...I'd say it is beginning to pull the nose up ...just an observation ...this is a ridiculous price and will double come Jan. IMHO
If ROSG was privately held and was now going to issue an IPO, I think they'd get a price several times the current price. Approved products using patented science would make them a speculative buy on everyone's list. Unfortunately, the IPO was long ago and even the big secondary that increased shares by 200% (a virtual IPO), was at a price twice the current value.
Let's hope that management is going for a SB win rather than just trying to avoid a shut-out. A buy-out now would be the biggest disappointment for anyone who has held for more than a couple of months.